Cynata Therapeutics secures $8.1m funding after promising results from diabetic foot ulcers trial
Cynata Therapeutics Limited, a clinical-stage biotechnology company listed on the Australian Securities Exchange (ASX: CYP), has raised A$8.1 million through an institutional placement. The funding ... Read More
Revolutionary breakthrough? New trial by StimLabs could change future of diabetic wound care
StimLabs, a pioneer in regenerative medicine, has initiated the CAMPSTIM trial, a groundbreaking multi-center randomized controlled trial aimed at assessing the effectiveness of its innovative ... Read More